Alector

Alector Days Payable Outstanding

The Days Payable Outstanding (DPO) of Alector (ALEC) as of Oct 27, 2026 is 63.89. In the previous year, Days Payable Outstanding (DPO) was 4.35 — a change of 1,369.33% (higher).

Days Payable Outstanding

63.89

YoY

1,369.33%

Last updated:

Days Payable Outstanding (DPO) of Alector is 2025 63.89 . Days Payable Outstanding (DPO) of Alector was 2024 4.35 . It decreases by 1,369.33% higher compared to the previous year.

The Alector Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
0.63 USD
Jan 1, 2019
1.01 USD
Jan 1, 2020
6.99 USD
Jan 1, 2021
9.15 USD
Jan 1, 2022
180.48 USD
Jan 1, 2023
155.73 USD
Jan 1, 2024
4.35 USD
Jan 1, 2025
63.89 USD
The Alector Days Payable Outstanding history
YEARDays Payable OutstandingYoY
63.89+1,369.33%
4.35-97.21%
155.73-13.71%
180.48+1,872.05%
9.15+30.93%
6.99+592.48%
1.01+60.29%
0.63-95.47%
13.91-54.76%
30.75—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alector Stock analysis

What does Alector do? Alector Inc. is a biotechnology company that was founded in 2013. The company's core competency is developing targeted therapies for previously incurable neurodegenerative diseases. The company is based in South San Francisco, California, and was founded by a group of renowned scientists. The founders aimed to develop innovative approaches to treat Alzheimer's and other neurodegenerative diseases by drawing inspiration from the processes of the immune system. Alector has a unique business model based on identifying antibodies to combat neurodegeneration. The company works closely with academics, pharmaceutical partners, and clinicians to develop drug candidates targeting various aspects of these serious diseases. Alector has developed a platform technology called the "Lead-Selective Integrated Discovery Platform" (LSP) that sets it apart. This platform is capable of identifying specific antibodies that can help inhibit disease mechanisms in neurodegenerative diseases. Alector has several products in various stages of development. A promising drug, AL001, is currently in Phase 1b/2a of clinical development for the treatment of Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). The drug aims to prevent overactivation of the immune system in the brain, which can contribute to disease symptoms. The company is also working on another drug, AL002, targeting Alzheimer's disease. It is still in preclinical development. Alector has also entered into a partnership with AbbVie Inc. (NYSE: ABBV) to develop antibody-based therapies for Alzheimer's disease and other neurological disorders. In addition to developing drug candidates, Alector also collaborates with other companies to make its technology platform accessible to other industries. In 2019, the company signed an agreement with GlaxoSmithKline plc (NYSE: GSK) granting GlaxoSmithKline access to the LSP platform. In summary, Alector Inc. is a leading biotechnology company specializing in the development of antibody-based therapies for neurodegenerative diseases. With innovative technology platforms and partnerships with other companies, Alector aims to create new treatment options for incurable diseases such as Alzheimer's and ALS. Alector is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alector stock

Days Payable Outstanding (DPO) of Alector is 63.89 in 2025.

Days Payable Outstanding (DPO) of Alector changed from 4.35 to 63.89, representing a 1,369.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Alector since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Alector with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Alector

All Key Metrics — Alector